BerGenBio ASA
Patents, Design & Utilities
Last updated:
List of all BerGenBio ASA patents 15 in total
| Status | Patent |
|---|---|
Application | Utility: Anti-Axl Antagonistic Antibodies Filling date: 7 Sep 2025 Issue date: 23 Jun 2022 |
Application | Utility: ANTI-AXL ANTIBODIES Filling date: 7 Sep 2025 Issue date: 16 Jun 2022 |
Application | Utility: HUMANIZED ANTI-AXL ANTIBODIES Filling date: 7 Sep 2025 Issue date: 10 Mar 2022 |
Grant | Utility: Anti-Axl antagonistic antibodies Filling date: 7 Sep 2025 Issue date: 14 Dec 2021 |
Grant | Utility: Anti-Axl antibodies Filling date: 7 Sep 2025 Issue date: 30 Nov 2021 |
Application | Utility: Serum Biomarkers Filling date: 7 Sep 2025 Issue date: 15 Jul 2021 |
Grant | Utility: Humanized anti-AXL antibodies Filling date: 7 Sep 2025 Issue date: 13 Jul 2021 |
Grant | Utility: Biomarkers for cancer Filling date: 7 Sep 2025 Issue date: 15 Jun 2021 |
Application | Utility: Anti-Axl Antagonistic Antibodies Filling date: 7 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: Pharmaceutically Active Compounds Filling date: 7 Sep 2025 Issue date: 11 Mar 2021 |
Grant | Utility: Pharmaceutically active compounds Filling date: 7 Sep 2025 Issue date: 8 Sep 2020 |
Application | Utility: COMBINATION THERAPY WITH AXL INHIBITOR AND IMMUNE CHECKPOINT MODULATOR OR ONCOLYTIC VIRUS Filling date: 7 Sep 2025 Issue date: 9 Jul 2020 |
Application | Utility: METHOD Filling date: 7 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: Pharmaceutically Active Compounds Filling date: 7 Sep 2025 Issue date: 9 Jan 2020 |
Application | Utility: HUMANIZED ANTI-AXL ANTIBODIES Filling date: 7 Sep 2025 Issue date: 21 Nov 2019 |
Showing 1 to 15 of 15 patents.